Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Angina Pectoris/MI
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Angina Pectoris/MI
    Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis - (N Engl J Med)
    FX06 Improves Outcomes After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: Presented at ESC - (DGDispatch)
    On-Pump Preferred to Off-Pump Revascularisation for Patients With Multivessel Chronic Coronary Artery Disease: Presented at ESC - (DGDispatch)
    TopAbstracts in Angina Pectoris/MI 09/03/2008 - (DGNews)
    Carotid Artery Bypass Graft Better Than Percutaneous Coronary Intervention for Patients With Left Main Disease and/or Severe 3-Vessel Disease: Presented at ESC - (DGDispatch)

    News archive

     Recent webcasts/CME - Angina Pectoris/MI
    • Late Breaking Data From Clinical Trials on RAAS Inhibition
    • The Changing Landscape in the Management of Hypertension and Cardiovascular Risk
    • Beyond the Management of Hypertension With RAAS Inhibitors: A Guide for General Practitioners
    • Understanding Metabolic Dysfunction in HIV
    • Importance of Reducing Ischemic Time for Optimal Treatment of ST Elevation MI

      Webcasts/CME archive

       Recent cases - Angina Pectoris/MI
        Acute Myocardial Infarction in an 18 Year Old South Indian Girl with Familial Hypercholesterolemia: A Case Report
        The Effect of a Large Proximal Haemodialysis A-V Fistula on Weaning off Cardiopulmonary Bypass
        Diagnostic Uncertainty of Takotusbo Cardiomyopathy Presenting as Acute Myocardial Infarction in a Woman with Cardiovascular Risk Factors Hijacked at Gunpoint: A Case Report
        The Role of Intravascular Ultrasound in the Management of Spontaneous Coronary Artery Dissection
        Unusual Cause of Exercise-Induced Ventricular Fibrillation in a Well-Trained Adult Endurance Athlete: A Case Report

        Cases archive
          




        my personal edition > angina pectoris/mi > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Fluvastatin Reduces Myocardial Ischaemia in Patients With Coronary Heart Disease: Presented at ISA

        By Eurona Earl Tilley

        KYOTO, JAPAN -- September 30 -- Fluvastatin therapy was shown to reduce the number of transient ischaemic episodes in patients with coronary heart disease (CHD).

        In a study presented here September 29th at the 13th International Symposium on Atherosclerosis, Claudia Abletshauser, PhD, Medical Department, Novartis Pharma, Nurenberg, Germany, illustrated that the total ischaemic burden during a 48 hour electrocardiogram (ECG), was reduced from a median of 50.2 mm/min (mean 76.8 mm/min) to 0.0 mm/min (mean 32.1 mm/min) in patients treated with fluvastatin.

        Dr. Abletshauser and colleagues studied 34 patients with CHD, a low-density lipoprotein (LDL) cholesterol level between 130 and 200 mg/dL, and at least 1 transient ischaemic episode within a 48 hour Holter monitoring period.

        Patients did not receive statin therapy for 12 weeks prior to the beginning of the study, and underwent a dietary run-in period of 4 weeks. Eligible participants were treated with 40 mg of fluvastatin for a 12-week period in addition to their usual antihypertensive and anti-anginal medications.

        The researchers used random codes for the tapes and kept records in an observer-blinded manner. One patient was removed from the study as a result of unstable angina pectoris.

        Transient ischaemic burden was defined as ST-segment depression of 1mm or greater, and duration of 1 minute or greater. The results show that the median number of ischaemic episodes decreased from 2.0 to 0.0, and 60% of participants experienced total resolution of ischaemic episodes. The incidence of transient ischaemic episodes was reduced by nearly 80%, according to the researchers.

        A comparison of each patient's lipoprotein level at baseline and at week 12 illustrates a 25% decrease in mean LDL cholesterol level, an 18% decrease in apolipoprotein B level, and a 5% decrease in high-density lipoprotein (HDL) cholesterol level as a result of this therapy.

        In closing, Dr. Abletshauser stressed that although lifestyle changes, including a healthier diet, may have slightly contributed to the findings, fluvastatin therapy significantly reduced myocardial ischaemia in patients with hypercholesterolaemia and ischaemic heart disease.


        [Study title: Patients With Ischaemic Heart Disease Show Benefit With Fluvastatin Therapy During 48-h Ambulatory ECG. Abstract 1P-0020]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send